{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["autophagy", "escin", "lung cancer", "sorafenib", "synergy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37468281", "DateRevised": {"Year": "2023", "Month": "10", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7948"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "37", "Issue": "10", "PubDate": {"Year": "2023", "Month": "Oct"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells.", "Pagination": {"StartPage": "4819", "EndPage": "4837", "MedlinePgn": "4819-4837"}, "Abstract": {"AbstractText": ["Combining anti-cancer drugs has been exploited as promising treatment strategy to target lung cancer. Synergistic chemotherapies increase anti-cancer effect and reduce effective drug doses and side effects. In this study, therapeutic potential of escin in combination with sorafenib has been explored. 3-(4,5-Dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide assay was used to calculate IC<sub>50</sub> values. The synergy was evaluated using Chou-Talaly algorithm. Cellular reactive oxygen species, mitochondrial membrane potential, annexin V, and cell-cycle studies were done by flow-cytometer, and autophagy biomarkers expression were determined using western blotting. Moreover, autophagy was knocked down using ATG5 siRNA to confirm its role, diethylnitrosamine-induced lung cancer model was used to check the synergy of sorafenib/escin. Escin significantly reduced the IC<sub>50</sub> of sorafenib in A549 and NCIH460 cells. The combination of sorafenib/escin produced a 2.95 and 5.45 dose reduction index for sorafenib in A549 and NCI-H460 cells. The combination of over-expressed p62 and LC3-II reflects autophagy block-mediated late apoptosis. This phenomenon was reconfirmed by ATG5 knockdown. This combination also selectively targeted G0/G1 phase of cancer cells. In in vivo study, the combination reduced tumour load and lower elevated serum biochemical parameters. The combination of sorafenib/escin synergistically inhibits autophagy to induce late apoptosis in lung cancer cells' G0/G1 phase."], "CopyrightInformation": "\u00a9 2023 John Wiley & Sons, Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Hussain", "ForeName": "Yusuf", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Jawaharlal Nehru University, New Delhi, India."}], "LastName": "Singh", "ForeName": "Jyoti", "Initials": "J"}, {"Identifier": ["0000-0002-1014-1486"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Meena", "ForeName": "Abha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India."}], "LastName": "Sinha", "ForeName": "Rohit Anthony", "Initials": "RA"}, {"Identifier": ["0000-0001-6568-8107"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}], "GrantList": [{"GrantID": "HCP-007", "Agency": "CSIR-CIMAP Aroma Mission Phase II", "Country": ""}, {"GrantID": "DU2/MLP-11", "Agency": "CSIR-CIMAP", "Country": ""}, {"GrantID": "59/05/2019/ONLINE/ BMS/TRM", "Agency": "ICMR", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdel-Moneim, A., Ahmed, O. M., Abd El-Twab, S. M., Zaky, M. Y., & Bakry, L. N. (2021). Prophylactic effects of Cynara scolymus L. leaf and flower hydroethanolic extracts against diethylnitrosamine/acetylaminoflourene-induced lung cancer in Wistar rats. Environmental Science and Pollution Research International, 28(32), 43515-43527. https://doi.org/10.1007/s11356-021-13391-x"}, {"Citation": "Alexander, M., Kim, S. Y., & Cheng, H. (2020). Update 2020: Management of non-small cell lung cancer. Lung, 198(6), 897-907. https://doi.org/10.1007/s00408-020-00407-5"}, {"Citation": "Atale, N., Gupta, S., Yadav, U. C., & Rani, V. (2014). Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques. Journal of Microscopy, 255(1), 7-19. https://doi.org/10.1111/jmi.12133"}, {"Citation": "Bhutia, S. K., Mukhopadhyay, S., Sinha, N., Das, D. N., Panda, P. K., Patra, S. K., Maiti, T. K., Mandal, M., Dent, P., Wang, X.-Y., Das, S. K., Sarkar, D., & Fisher, P. B. (2013). Autophagy: Cancer's friend or foe? Advances in Cancer Research, 118, 61-95. https://doi.org/10.1016/B978-0-12-407173-5.00003-0"}, {"Citation": "Bijnsdorp, I. V., Giovannetti, E., & Peters, G. J. (2011). Analysis of drug interactions. Methods in Molecular Biology, 731, 421-434. https://doi.org/10.1007/978-1-61779-080-5_34"}, {"Citation": "Blumenschein, G., Jr. (2008). Sorafenib in lung cancer: Clinical developments and future directions. Journal of Thoracic Oncology, 3(6 Suppl 2), S124-S127. https://doi.org/10.1097/JTO.0b013e318174e085"}, {"Citation": "Chavez-Dominguez, R., Perez-Medina, M., Lopez-Gonzalez, J. S., Galicia-Velasco, M., & Aguilar-Cazares, D. (2020). The double-edge sword of autophagy in cancer: From tumor suppression to pro-tumor activity. Frontiers in Oncology, 10, 578418. https://doi.org/10.3389/fonc.2020.578418"}, {"Citation": "Cheng, C. L., Chao, W. T., Li, Y. H., Ou, Y. C., Wang, S. S., Chiu, K. Y., & Yuan, S. Y. (2018). Escin induces apoptosis in human bladder cancer cells: An in vitro and in vivo study. European Journal of Pharmacology, 840, 79-88. https://doi.org/10.1016/j.ejphar.2018.09.033"}, {"Citation": "Cheong, D. H. J., Arfuso, F., Sethi, G., Wang, L., Hui, K. M., Kumar, A. P., & Tran, T. (2018). Molecular targets and anti-cancer potential of escin. Cancer Letters, 422, 1-8. https://doi.org/10.1016/j.canlet.2018.02.027"}, {"Citation": "Chou, T. C. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Research, 70(2), 440-446. https://doi.org/10.1158/0008-5472.CAN-09-1947"}, {"Citation": "Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2019). Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Frontiers in Pharmacology, 10, 1614. https://doi.org/10.3389/fphar.2019.01614"}, {"Citation": "Cottet-Rousselle, C., Ronot, X., Leverve, X., & Mayol, J. F. (2011). Cytometric assessment of mitochondria using fluorescent probes. Cytometry. Part A, 79(6), 405-425. https://doi.org/10.1002/cyto.a.21061"}, {"Citation": "Darzynkiewicz, Z., Juan, G., & Bedner, E. (2001). Determining cell cycle stages by flow cytometry. Current Protocols in Cell Biology, Chapter 8, Unit 8 4. https://doi.org/10.1002/0471143030.cb0804s01"}, {"Citation": "Denizot, F., & Lang, R. (1986). Rapid colorimetric assay for cell growth and survival. modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods, 89(2), 271-277. https://doi.org/10.1016/0022-1759(86)90368-6"}, {"Citation": "Duarte, D., & Vale, N. (2022). Evaluation of synergism in drug combinations and reference models for future orientations in oncology. Current Research in Pharmacology and Drug Discovery, 3, 100110. https://doi.org/10.1016/j.crphar.2022.100110"}, {"Citation": "El-Ashmawy, N. E., Khedr, E. G., El-Bahrawy, H. A., & Abd El-Fattah, E. E. (2017). Sorafenib effect on liver neoplastic changes in rats: More than a kinase inhibitor. Clinical and Experimental Medicine, 17(2), 185-191. https://doi.org/10.1007/s10238-016-0416-3"}, {"Citation": "Eruslanov, E., & Kusmartsev, S. (2010). Identification of ROS using oxidized DCFDA and flow-cytometry. Methods in Molecular Biology, 594, 57-72. https://doi.org/10.1007/978-1-60761-411-1_4"}, {"Citation": "Gallelli, L. (2019). Escin: A review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug Design, Development and Therapy, 13, 3425-3437. https://doi.org/10.2147/DDDT.S207720"}, {"Citation": "Graef, M., & Nunnari, J. (2011). A role for mitochondria in autophagy regulation. Autophagy, 7(10), 1245-1246. https://doi.org/10.4161/auto.7.10.16508"}, {"Citation": "Gridelli, C., Morgillo, F., Favaretto, A., de Marinis, F., Chella, A., Cerea, G., Mattioli, R., Tortora, G., Rossi, A., Fasano, M., Pasello, G., Ricciardi, S., Maione, P., Di Maio, M., & Ciardiello, F. (2011). Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: A randomized phase II study. Annals of Oncology, 22(7), 1528-1534. https://doi.org/10.1093/annonc/mdq630"}, {"Citation": "He, C., & Klionsky, D. J. (2009). Regulation mechanisms and signaling pathways of autophagy. Annual Review of Genetics, 43, 67-93. https://doi.org/10.1146/annurev-genet-102808-114910"}, {"Citation": "He, L., Long, L. R., Antani, S., & Thoma, G. R. (2012). Histology image analysis for carcinoma detection and grading. Computer Methods and Programs in Biomedicine, 107(3), 538-556. https://doi.org/10.1016/j.cmpb.2011.12.007"}, {"Citation": "Hussain, Y., Luqman, S., & Meena, A. (2020). Research Progress in flavonoids as potential anticancer drug including synergy with other approaches. Current Topics in Medicinal Chemistry, 20(20), 1791-1809. https://doi.org/10.2174/1568026620666200502005411"}, {"Citation": "Hussain, Y., Singh, J., Raza, W., Meena, A., Rajak, S., Sinha, R. A., & Luqman, S. (2022). Purpurin ameliorates alcohol-induced hepatotoxicity by reducing ROS generation and promoting Nrf2 expression. Life Sciences, 309, 120964. https://doi.org/10.1016/j.lfs.2022.120964"}, {"Citation": "Ianevski, A., Timonen, S., Kononov, A., Aittokallio, T., & Giri, A. K. (2020). SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy. PLoS Computational Biology, 16(2), e1007604. https://doi.org/10.1371/journal.pcbi.1007604"}, {"Citation": "Idris, S., Mishra, A., & Khushtar, M. (2020). Phytochemical, ethanomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine. Journal of Basic and Clinical Physiology and Pharmacology, 31(5), 1-13. https://doi.org/10.1515/jbcpp-2019-0115"}, {"Citation": "Kenny, H. A., Hart, P. C., Kordylewicz, K., Lal, M., Shen, M., Kara, B., Chen, Y. J., Grassl, N., Alharbi, Y., Pattnaik, B. R., Watters, K. M., Patankar, M. S., Ferrer, M., & Lengyel, E. (2021). The natural product beta-Escin targets cancer and stromal cells of the tumor microenvironment to inhibit ovarian cancer metastasis. Cancers (Basel), 13(16), 3931. https://doi.org/10.3390/cancers13163931"}, {"Citation": "Kurma, K., Manches, O., Chuffart, F., Sturm, N., Gharzeddine, K., Zhang, J., Mercey-Ressejac, M., Rousseaux, S., Millet, A., Lerat, H., Marche, P. N., Macek Jilkova, Z., & Decaens, T. (2021). DEN-induced rat model reproduces key features of human hepatocellular carcinoma. Cancers (Basel), 13(19), 4981. https://doi.org/10.3390/cancers13194981"}, {"Citation": "Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017). Targeting autophagy in cancer. Nature Reviews. Cancer, 17(9), 528-542. https://doi.org/10.1038/nrc.2017.53"}, {"Citation": "Li, B., Wu, G. L., Dai, W., Wang, G., Su, H. Y., Shen, X. P., Zhan, R., Xie, J. M., Wang, Z., Qin, Z. H., Gao, Q. G., & Shen, G. H. (2018). Aescin-induced reactive oxygen species play a pro-survival role in human cancer cells via ATM/AMPK/ULK1-mediated autophagy. Acta Pharmacologica Sinica, 39(12), 1874-1884. https://doi.org/10.1038/s41401-018-0047-1"}, {"Citation": "Liang, C. C., Park, A. Y., & Guan, J. L. (2007). In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols, 2(2), 329-333. https://doi.org/10.1038/nprot.2007.30"}, {"Citation": "Lim, S. M., Mohamad Hanif, E. A., & Chin, S. F. (2021). Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect. Cell & Bioscience, 11(1), 56. https://doi.org/10.1186/s13578-021-00570-z"}, {"Citation": "Liu, T., Zhang, J., Li, K., Deng, L., & Wang, H. (2020). Combination of an autophagy inducer and an autophagy inhibitor: A smarter strategy emerging in cancer therapy. Frontiers in Pharmacology, 11, 408. https://doi.org/10.3389/fphar.2020.00408"}, {"Citation": "Liu, Z. Q., Mahmood, T., & Yang, P. C. (2014). Western blot: Technique, theory and trouble shooting. North American Journal of Medical Sciences, 6(3), 160. https://doi.org/10.4103/1947-2714.128482"}, {"Citation": "Liu, Z. R., Sun, L. Z., Jia, T. H., & Jia, D. F. (2017). Beta-Aescin shows potent antiproliferative activity in osteosarcoma cells by inducing autophagy, ROS generation and mitochondrial membrane potential loss. Journal of BUON, 22(6), 1582-1586."}, {"Citation": "Marino, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014). Self-consumption: The interplay of autophagy and apoptosis. Nature Reviews. Molecular Cell Biology, 15(2), 81-94. https://doi.org/10.1038/nrm3735"}, {"Citation": "Mathew, R., Karantza-Wadsworth, V., & White, E. (2007). Role of autophagy in cancer. Nature Reviews. Cancer, 7(12), 961-967. https://doi.org/10.1038/nrc2254"}, {"Citation": "Miller, E. (2004). Apoptosis measurement by annexin v staining. Methods in Molecular Medicine, 88, 191-202. https://doi.org/10.1385/1-59259-406-9:191"}, {"Citation": "Moshawih, S., Goh, H. P., Kifli, N., Idris, A. C., Yassin, H., Kotra, V., Goh, K. W., Liew, K. B., & Ming, L. C. (2022). Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives. Chemical Biology & Drug Design, 100(2), 185-217. https://doi.org/10.1111/cbdd.14062"}, {"Citation": "Mou, L., Tian, X., Zhou, B., Zhan, Y., Chen, J., Lu, Y., Deng, J., Deng, Y., Wu, Z., Li, Q., Song, Y., Zhang, H., Chen, J., Tian, K., Ni, Y., & Pu, Z. (2021). Improving outcomes of tyrosine kinase inhibitors in hepatocellular carcinoma: New data and ongoing trials. Frontiers in Oncology, 11, 752725. https://doi.org/10.3389/fonc.2021.752725"}, {"Citation": "Neophytou, C. M., Kyriakou, T. C., & Papageorgis, P. (2019). Mechanisms of metastatic tumor dormancy and implications for cancer therapy. International Journal of Molecular Sciences, 20(24), 6158. https://doi.org/10.3390/ijms20246158"}, {"Citation": "Omi, K., Matsuo, Y., Ueda, G., Aoyama, Y., Kato, T., Hayashi, Y., Imafuji, H., Saito, K., Tsuboi, K., Morimoto, M., Ogawa, R., Takahashi, H., & Takiguchi, S. (2021). Escin inhibits angiogenesis by suppressing interleukin-8 and vascular endothelial growth factor production by blocking nuclear factor-kappaB activation in pancreatic cancer cell lines. Oncology Reports, 45(5), 55. https://doi.org/10.3892/or.2021.8006"}, {"Citation": "Park, S., Park, J. M., Park, M., Ko, D., Kim, S., Seo, J., Nam, K. D., Jung, E., Farrand, L., Kim, Y. J., Kim, J. Y., & Seo, J. H. (2022). Beta-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features. Cancer Cell International, 22(1), 289. https://doi.org/10.1186/s12935-022-02713-9"}, {"Citation": "Patlolla, J. M., Raju, J., Swamy, M. V., & Rao, C. V. (2006). Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Molecular Cancer Therapeutics, 5(6), 1459-1466. https://doi.org/10.1158/1535-7163.MCT-05-0495"}, {"Citation": "Paz-Ares, L., Hirsh, V., Zhang, L., de Marinis, F., Yang, J. C., Wakelee, H. A., Seto, T., Wu, Y. L., Novello, S., Juh\u00e1sz, E., Ar\u00e9n, O., Sun, Y., Schmelter, T., Ong, T. J., Pe\u00f1a, C., Smit, E. F., & Mok, T. S. (2015). Monotherapy Administration of Sorafenib in patients with non-small cell lung cancer (MISSION) trial: A phase III, multicenter, placebo-controlled trial of Sorafenib in patients with relapsed or refractory predominantly nonsquamous non-small-cell lung cancer after 2 or 3 previous treatment regimens. Journal of Thoracic Oncology, 10(12), 1745-1753. https://doi.org/10.1097/JTO.0000000000000693"}, {"Citation": "Paz-Ares, L. G., Biesma, B., Heigener, D., von Pawel, J., Eisen, T., Bennouna, J., Zhang, L., Liao, M., Sun, Y., Gans, S., Syrigos, K., Le Marie, E., Gottfried, M., Vansteenkiste, J., Alberola, V., Strauss, U. P., Montegriffo, E., Ong, T. J., Santoro, A., \u2026 NSCLC [non-small-cell lung cancer] Research Experience Utilizing Sorafenib (NExUS) Investigators Study Group. (2012). Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer. Journal of Clinical Oncology, 30(25), 3084-3092. https://doi.org/10.1200/JCO.2011.39.7646"}, {"Citation": "Pezzani, R., Salehi, B., Vitalini, S., Iriti, M., Zuniga, F. A., Sharifi-Rad, J., Martorell, M., & Martins, N. (2019). Synergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective. Medicina (Kaunas, Lithuania), 55(4), 110. https://doi.org/10.3390/medicina55040110"}, {"Citation": "Piao, S., Kang, M., Lee, Y. J., Choi, W. S., Chun, Y. S., Kwak, C., & Kim, H. H. (2014). Cytotoxic effects of escin on human castration-resistant prostate cancer cells through the induction of apoptosis and G2/M cell cycle arrest. Urology, 84(4), 982.e981-982.e987. https://doi.org/10.1016/j.urology.2014.06.019"}, {"Citation": "Qiao, P., Zhang, B., Liu, X., Xu, J., & Li, X. (2022). Effects of Escin on oxidative stress and apoptosis of H9c2 cells induced by H(2)O(2). Disease Markers, 2022, 7765353. https://doi.org/10.1155/2022/7765353"}, {"Citation": "Raafat, M., Kamel, A. A., Shehata, A. H., Ahmed, A. F., Bayoumi, A. M. A., Moussa, R. A., Abourehab, M. A. S., & El-Daly, M. (2022). Aescin protects against experimental benign prostatic hyperplasia and preserves prostate histomorphology in rats via suppression of inflammatory cytokines and COX-2. Pharmaceuticals (Basel), 15(2), 130. https://doi.org/10.3390/ph15020130"}, {"Citation": "Raffetto, J. D., & Khalil, R. A. (2011). Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: Implications in venotonic treatment of varicose veins. Journal of Vascular Surgery, 54(2), 489-496. https://doi.org/10.1016/j.jvs.2011.01.043"}, {"Citation": "Riggio, A. I., Varley, K. E., & Welm, A. L. (2021). The lingering mysteries of metastatic recurrence in breast cancer. British Journal of Cancer, 124(1), 13-26. https://doi.org/10.1038/s41416-020-01161-4"}, {"Citation": "Rizeq, B., Gupta, I., Ilesanmi, J., AlSafran, M., Rahman, M. M., & Ouhtit, A. (2020). The power of phytochemicals combination in cancer chemoprevention. Journal of Cancer, 11(15), 4521-4533. https://doi.org/10.7150/jca.34374"}, {"Citation": "Shimizu, S., Takehara, T., Hikita, H., Kodama, T., Tsunematsu, H., Miyagi, T., Hosui, A., Ishida, H., Tatsumi, T., Kanto, T., Hiramatsu, N., Fujita, N., Yoshimori, T., & Hayashi, N. (2012). Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. International Journal of Cancer, 131(3), 548-557. https://doi.org/10.1002/ijc.26374"}, {"Citation": "Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17-48. https://doi.org/10.3322/caac.21763"}, {"Citation": "Singh, S., Sharma, B., Kanwar, S. S., & Kumar, A. (2016). Lead phytochemicals for anticancer drug development. Frontiers in Plant Science, 7, 1667. https://doi.org/10.3389/fpls.2016.01667"}, {"Citation": "Sun, T., Liu, H., & Ming, L. (2017). Multiple roles of autophagy in the Sorafenib resistance of hepatocellular carcinoma. Cellular Physiology and Biochemistry, 44(2), 716-727. https://doi.org/10.1159/000485285"}, {"Citation": "Thorburn, A. (2008). Apoptosis and autophagy: Regulatory connections between two supposedly different processes. Apoptosis, 13(1), 1-9. https://doi.org/10.1007/s10495-007-0154-9"}, {"Citation": "Torkamannia, A., Omidi, Y., & Ferdousi, R. (2022). A review of machine learning approaches for drug synergy prediction in cancer. Briefings in Bioinformatics, 23(3), bbac075. https://doi.org/10.1093/bib/bbac075"}, {"Citation": "Underland, V., Saeterdal, I., & Nilsen, E. S. (2012). Cochrane summary of findings: Horse chestnut seed extract for chronic venous insufficiency. Global Advances in Health and Medicine, 1(1), 122-123. https://doi.org/10.7453/gahmj.2012.1.1.018"}, {"Citation": "Vaskova, J., Fejercakova, A., Mojzisova, G., Vasko, L., & Patlevic, P. (2015). Antioxidant potential of Aesculus hippocastanum extract and escin against reactive oxygen and nitrogen species. European Review for Medical and Pharmacological Sciences, 19(5), 879-886."}, {"Citation": "Xie, Q., Liu, Y., & Li, X. (2020). The interaction mechanism between autophagy and apoptosis in colon cancer. Translational Oncology, 13(12), 100871. https://doi.org/10.1016/j.tranon.2020.100871"}, {"Citation": "Yano, S., Miwa, S., Mii, S., Hiroshima, Y., Uehara, F., Kishimoto, H., Tazawa, H., Zhao, M., Bouvet, M., Fujiwara, T., & Hoffman, R. M. (2015). Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional Gelfoam(R) histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging. Cell Cycle, 14(6), 808-819. https://doi.org/10.1080/15384101.2014.1000685"}, {"Citation": "Youn, D. H., Kim, Y., Kim, B. J., Jeong, M. S., Lee, J., Rhim, J. K., Kim, H. C., & Jeon, J. P. (2021). Mitochondrial dysfunction associated with autophagy and mitophagy in cerebrospinal fluid cells of patients with delayed cerebral ischemia following subarachnoid hemorrhage. Scientific Reports, 11(1), 16512. https://doi.org/10.1038/s41598-021-96092-2"}, {"Citation": "Yuan, S. Y., Cheng, C. L., Wang, S. S., Ho, H. C., Chiu, K. Y., Chen, C. S., Chen, C. C., Shiau, M. Y., & Ou, Y. C. (2017). Escin induces apoptosis in human renal cancer cells through G2/M arrest and reactive oxygen species-modulated mitochondrial pathways. Oncology Reports, 37(2), 1002-1010. https://doi.org/10.3892/or.2017.5348"}, {"Citation": "Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y., & Dong, W. (2016). ROS and ROS-mediated cellular signaling. Oxidative Medicine and Cellular Longevity, 2016, 4350965. https://doi.org/10.1155/2016/4350965"}, {"Citation": "Zhu, J., Yu, W., Liu, B., Wang, Y., Shao, J., Wang, J., Xia, K., Liang, C., Fang, W., Zhou, C., & Tao, H. (2017). Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death & Disease, 8(10), e3113. https://doi.org/10.1038/cddis.2017.488"}, {"Citation": "Zhu, M., Ying, J., Lin, C., Wang, Y., Huang, K., Zhou, Y., & Teng, H. (2018). Beta-Escin inhibits the proliferation of osteosarcoma cells via blocking the PI3K/Akt pathway. RSC Advances, 8(52), 29637-29644. https://doi.org/10.1039/c8ra03578d"}, {"Citation": "Zhu, Y. J., Zheng, B., Wang, H. Y., & Chen, L. (2017). New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacologica Sinica, 38(5), 614-622. https://doi.org/10.1038/aps.2017.5"}, {"Citation": "Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews, 94(3), 909-950. https://doi.org/10.1152/physrev.00026.2013"}, {"Citation": "Zurlo, J. (2005). Report on the ILAR international workshop on the development of science-based guidelines for laboratory animal care. ILAR Journal, 46(4), 370-373. https://doi.org/10.1093/ilar.46.4.370"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "6", "Day": "25"}, {"Year": "2023", "Month": "2", "Day": "23"}, {"Year": "2023", "Month": "6", "Day": "27"}, {"Year": "2023", "Month": "7", "Day": "20", "Hour": "1", "Minute": "6"}, {"Year": "2023", "Month": "7", "Day": "20", "Hour": "1", "Minute": "6"}, {"Year": "2023", "Month": "7", "Day": "19", "Hour": "21", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37468281", "10.1002/ptr.7948"]}}], "PubmedBookArticle": []}